Helicobacter pylori in liver diseases

Journal of Physiology and Pharmacology

Volumn 57, Issue SUPPL. 3, 2006, Pages 155-161

  Gonciarz, Maciej ^a   Wloch M ^a   Gonciarz, Z ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Biliary tract; Hepatic diseases; Liver

Indexed keywords

ALCOHOL;

ARTICLE; CHOLELITHIASIS; CHRONIC LIVER DISEASE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HEMATOPOIETIC STEM CELL; HEPATIC ENCEPHALOPATHY; HUMAN; LIVER CELL CARCINOMA; LIVER DISEASE; LIVER TUMOR; PATHOGENESIS; PATHOPHYSIOLOGY; STEM CELL;

ANIMALS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; LIVER DISEASES;

EID: 33750373591     PISSN: 08675910     EISSN: 08675910     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Fox JG, Yan L, Shames B, et al. Persistent hepatitis and enterocolitis in germfree mice infected with Helicobacter hepaticus. Infect Immun 1996; 64: 3673 - 3681.
2. Fox JG, Yan L, Dewhirst FE, et al. Helicobacter bilis sp. nov., a novel Helicobacter isolated from bile, livers, and intestines of aged, inbred mouse strains. J Clin Microbiol 1995; 33: 445 - 454.
3. Franklin CL, Beckwith CS, Livingston RS, et al. Isolation of a novel Helicobacter species, Helicobacter cholecystus sp. nov., from the gallbladders of Syrian hamsters with cholangiofibrosis and centrilobular pancreatitis. J Clin Microbiol 1996; 34: 2952 - 2958.
4. Hanninen ML. Sensitivity of Helicobacter pylori to different bile salts. Eur J Clin Microbiol Infect Dis 1991; 10: 515 - 518.
5. Nilsson H-O, Blom J, Abu Al -Soud W, et al. Effect of cold starvation, acid stress, and nutrients on metabolic activity of Helicobacter pylori infection in patients with hepatitis B. Br J Biomed Sci 1998; 55: 176 - 178.
6. Leong RWL, Sung JJY. Helicobacter species and hepatobiliary diseases. Aliment Pharmacol Ther 2002; 16: 1037 - 1045.
7. Kuntz E, Kuntz H.D. Hepatology. Principles and practice. Springer Medizin Verlag Heidelberg, 2006.
8. Suto H, Azuma T, Ito S, et al. Helicobacter pylori infection induces hyperammonaemia in Mongolian gerbils with liver cirrhosis. Gut 2001; 48: 605 - 608.
9. Blei A T. Helicobacter pylori, harmful to the brain? Gut 2001; 48: 590-591.
10. Dasani BM, Sigal SH, Lieber CS. Analysis of risk factors for chronic hepatic encephalopathy: The role of Helicobacter pylori infection. Am J Gastroenterol 1998; 93: 726 - 731.
11. Miyagi H, Ito S, Azuma T, et al. Effect of Helicobacter pylori eradication therapy on hyperammonemia in patients with liver cirrhosis. Gut 1997; 40: 726 -730.
12. Vásconez C, Elizalde JI, Llach J, et al. Helicobacter pylori, hyperammonemia and subclinical portosystemic encephalopathy: effects of eradication. J Hepatol 1999; 30: 260 - 264.
13. Nilsson HO, Taneera J, Castedal M, et al. Identification of Helicobacter pylori and other Helicobacter species by PCR, hybridization, and partial DNA sequencing in human liver samples from patients with primary sclerosing cholangitis or primary biliary cirrhosis. J Clin Microbiol 2000; 38: 1072 - 1076.
14. Nilsson HO, Castedal M, Olsson R, et al. Detection of Helicobacter pylori in the liver of patients with chronic cholestatic liver diseases. J Physiol Pharmacol 1999; 50, 5: 875 - 882.
15. Tanaka A, Prindiville TP, Gish R, et al: Are infectious agents involved in primary biliary cirrhosis? A PCR approach. J Hepatol 1999; 31: 664 - 671.
16. Konturek SJ, Gonciarz M, Gonciarz Z, et al. Progastrin and its products from patients with chronic viral hepatitis and liver cirrhosis. Scand J Gastroenterol 2003; 38: 643 - 647.
17. Stalke P, Abu Al-Soud W, Bielawski KP, et al. Detection of Helicobacter species in liver and stomach tissues of patients with chronic liver disease using polymerase chain reaction - denaturing gradient gel electrophoresis and immunohistochemistry. Scand J Gastroenterol 2005; 40: 1032 - 1041.
18. Vorobjova T, Nilsson I., Terjajev S, et al. Serum antibodies to enterohepatic Helicobacter spp. in patients with chronic liver diseases and in a population with high prevalence of H. pylori infection. Dig Liver Dis 2006; 38: 171 - 176.
19. McIntyre N. Biliary tract diseases. In Oxford Textbook of Clinical Hepatology. J Bircher, JP Benhamou, N McIntyre, M Rizetto J Rooles (eds). Oxford University Press, Oxford, N - York, Tokyo, 1999, p 1573.
20. Offner GD, Gong D, Afdhal NH. Identification of a 130 -kilodalton human biliary concavalin A binding protein as aminopeptidase N. Gastroenterology 1994; 106: 755- 762.
21. Figura N, Cetta F, Angelico M, et al. Most Helicobacter pylori - infected patients have specific antibodies, and some also have H. pylori antigens and genomic material in bile: Is it a risk factor for gallstone formation? Dig Dis Sci 1998; 43: 854.
22. Silva CP, Pereira JC, Gonçalves Oliveira A, et al. Association of the presence of Helicobacter in gallbladder tissue with cholelithiasis and cholecystitis. J Clin Microbiol 2003; 41: 5615 - 5618.
23. Apostolov E, Abu Al-Soud W, Nilsson I, et al. Helicobacter pylori and other Helicobacter species in gallbladder and liver of patients with chronic cholecystitis detected by immunological and molecular methods. Scand J Gastroenterol 2005; 40: 96 - 102.
24. Fox JG, Dewhirst FE, Shen Z, et al. Hepatic Helicobacter species identified in bile and gallbladder tissue from Chileans with chronic cholecystitis. Gastroenterology 1998; 114: 755 - 763.
25. Monstein HJ, Jonsson J, Zdolsek M, et al. Identification of Helicobacter pylori DNA in Human Cholesterol Gallstones. Scand J Gastroenterol 2002; 37: 112 - 119.
26. Harada K, Ozak S, Kono N, et al. Frequent molecular identification of Campylobacter but not Helicobacter genus in bile and biliary epithelium in hepatolithiasis. J Pathol 2001; 193: 218 - 223.
27. Fox JG, Li X, Yan L, et al. Chronic proliferative hepatitis in A/Jcr mice associated with persistent Helicobacter hepaticus infection; a model of helicobacter - induced carcinogenesis. Infect Immun 1996; 64: 1548 - 1558.
28. Avenaud P, Marais A, Monteiro L, et al. Detection of Helicobacter species in the liver of patients with and without primary liver carcinoma. Cancer 2000; 89: 1431 - 1439.
29. Nilsson HO, Mulchandani R, Tranberg KG, et al. Helicobacter species identified in liver from patients with cholangiocarcinoma and hepatocellular carcinoma. Gastroenterology 2001; 120: 323 - 324.
30. Bulajic M, Maisonneuve P, Schneider-Brachert W, et al. Helicobacter pylori and the risk of benign and malignant biliary tract disease. Cancer 2002; 95: 1946 - 1953.
31. Fukuda K, Kuroki T, Tajima Y, et al. Comparative analysis of Helicobacter DNAs and biliary pathology in patients with and without hepatobiliary cancer. Carcinogenesis 2002; 23: 1927 - 1932.
32. Li HC, Stoicov C, Rogers AB, Houghton J. Stem cells and cancer: evidence for bone morrow stem cells in epithelial cancers. World J Gastroenterol 2006; 12: 363 - 371.